Monday 31 August 2020

Reuters Health Report: Explainer: How common cold viruses are being used in vaccines from Russia, China

Reuters.com Newsletter

Explainer: How common cold viruses are being used in vaccines from Russia, China

The modified common cold viruses behind high-profile COVID-19 vaccine candidates from China's CanSino Biologics and Russia's Gamaleya Institute have been studied for decades, but are still not widely used.

Scientists see downsides to top COVID-19 vaccines from Russia, China

High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness, some experts say.

Nestle pays $2 billion to secure Aimmune's allergy treatment

Nestle plans to pay $2 billion to gain full ownership of peanut allergy treatment maker Aimmune Therapeutics, as the Swiss company expands its fast-growing health science business.

U.S. scraps Philips ventilator order in 2020 earnings blow

Philips said the U.S. Department of Health had cancelled most of an order for 43,000 ventilators, leading the Dutch medical equipment maker to cut its 2020 earnings outlook.

How a $13 device is helping Delhi fight the coronavirus

Twice a day, New Delhi health worker Kamal Kumari receives a flurry of WhatsApp messages from coronavirus patients, containing either a two-digit reading from a tiny medical device or a photo of its glowing display.

EU offers 400 million euros to WHO-led COVID-19 vaccine initiative

The European Commission said on Monday it would contribute 400 million euros ($476 million) to an initiative led by the World Health Organization to buy COVID-19 vaccines.

New Zealanders wear face masks as Auckland lockdown lifted

Schools and businesses reopened in Auckland on Monday after the lifting of a lockdown in New Zealand's largest city to contain the resurgence of the coronavirus, but face masks were made mandatory on public transport across the country.

Daiichi Sankyo's COVID-19 vaccine selected by Japanese drug discovery body

Daiichi Sankyo Co said on Monday that its mRNA-based COVID-19 vaccine candidate was selected for inclusion in a drug discovery program by the Japan Agency for Medical Research and Development.

Japan's tripling of coronavirus tests unlikely to improve fight, experts say

Japan's plan to more than triple its coronavirus testing is unlikely to improve its fight against the outbreak without an overhaul in the test approval process, which has kept daily coronavirus-testing well below capacity, experts say.

No cramming as new COVID rules take hold in South Korean capital

Private tuition centres shut for the first time in South Korea's capital on Monday and traffic was light on the first working day of tighter social-distancing rules aimed at halting a second wave of novel coronavirus infections.

Hong Kong to resume face-to-face school classes by late September

Hong Kong will resume face-to-face school classes from Sept. 23 as the Asian financial hub's authorities aim to wind back strict coronavirus restrictions, which kept around 900,000 students working at home for over four months.

Related Videos

CDC guidance on testing stirs confusion, criticism

CDC guidance on testing stirs confusion, criticism

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS